Publications

Search for any of these articles on PubMed

Cancer Mechanisms Research Program investigators are indicated in bold; co-authors who are primary members of other NCCC Research Programs are indicated in bold italics.

Ambros V (2004). The functions of animal microRNAs. Nature 431(7006):350-355.

Ambros V, Chen X (2007). The regulation of genes and genomes by small RNAs. Development 134(9):1635-1641.

*Amiel E, Nicholson-Dykstra S, Walters JJ, Higgs H, Berwin B (2007). Scavenger receptor-A functions in phagocytosis of E. coli by bone marrow dendritic cells. Exp Cell Res 313(7):1438-1448.

Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, Thorpe JE, Ihnat MA, Hamilton JW (2007). Exposure to arsenic at levels found in U.S. drinking water modifies expression in the mouse lung. Toxicol Sci 100(1):75-87.

*Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, Karagas MR (2006). Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 114(8):1193-1198.

*Andrew AS, Karagas MR, Hamilton JW (2003). Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer 104(3):263-268.

*Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G (2008). DNA repair polymorphisms modify bladder cancer risk: A multi-factor analytic strategy. Hum Hered 65(2):105-118.

*Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR (2006). Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 27(5):1030-1037.

*Andrew AS, Schned AR, Heaney JA, Karagas MR (2004). Bladder cancer risk and personal hair dye use. Int J Cancer 109(4):581-586.

*Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, O’Hara JA, Hamilton JW (2003). Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect 111(6):825-835.

Belenky P, Bogan KL, Brenner C (2007). NAD(+) metabolism in health and disease. Trends Biochem Sci 32(1):12-19.

Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C (2007). Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell 129(3):473-484.

Bieganowski P, Brenner C (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a preiss-handler independent route to NAD(+) in fungi and humans. Cell 117(4):495-502.

Bieganowski P, Shilinski K, Tsichlis PN, Brenner C (2004). Cdc123 and checkpoint forkhead associated with RING proteins control the cell cycle by controlling eIF2{gamma} abundance. J Biol Chem 279(43):44656-44666.

Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE (2007). RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 67(22):10849-10858.

Bodwell JE, Gosse JA, Nomikos AP, Hamilton JW (2006). Arsenic disruption of steroid receptor gene activation: Complex dose-response effects are shared by several steroid receptors. Chem Res Toxicol 19(12):1619-1629.

Bodwell JE, Kingsley LA, Hamilton JW (2004). Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: Complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol 17(8):1064-1076.

Brenner C (2003). "At the precarious cusp of oncogenomics." In: Brenner C, Duggan D (ed). Oncogenomics: Molecular Approaches to Cancer: John Wiley and Sons, pp. 3-13.

Chhabra ES, Higgs HN (2006). INF2 is a WASP homology 2 motif-containing formin that severs actin filaments and accelerates both polymerization and depolymerization. J Biol Chem 281(36):26754-26767.

Chittenden TW, Claes F, Lanahan AA, Autiero M, Palac RT, Tkachenko EV, Elfenbein A, Ruiz de Almodovar C, Dedkov E, Tomanek R, Li W, Westmore M, Singh JP, Horowitz A, Mulligan-Kehoe MJ, Moodie KL, Zhuang ZW, Carmeliet P, Simons M (2006). Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 10(6):783-795.

Cole CN, Scarcelli JJ (2006). Unravelling mRNA export. Nat Cell Biol 8(7):645-647.
Cole MD, Henriksson M (2006). 25 years of the c-Myc oncogene. Semin Cancer Biol 16(4):241.

*Couch RD, Browning RG, Honda T, Gribble GW, Wright DL, Sporn MB, Anderson AC (2005). Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: Implications for a molecular mechanism of action. Bioorg Med Chem Lett 15(9):2215-2219.

*Couch RD, Ganem NJ, Zhou M, Popov VM, Honda T, Veenstra TD, Sporn MB, Anderson AC (2006). 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: A possible mechanism contributing to apoptosis. Mol Pharmacol 69(4):1158-1165.

Cowling VH, Chandriani S, Whitfield ML, Cole MD (2006). A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest. Mol Cell Biol 26(11):4226-4239.

Cowling VH, Cole MD (2007). The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol 27(6):2059-2073.

Cowling VH, D'Cruz CM, Chodosh LA, Cole MD (2007). c-Myc transforms human mammary epithelial cells through repression of the Wnt Inhibitors DKK1 and SFRP1. Mol Cell Biol 27(14):5135-5146.

Davey JC, Bodwell JE, Gosse JA, Hamilton JW (2007). Arsenic as an endocrine disruptor: Effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98(1):75-86.

de Bruijn MF, Speck NA (2004). Core-binding factors in hematopoiesis and immune function. Oncogene 23(24):4238-4248.

Dmitrovsky E (2004). Tissue microarrays for hypothesis generation. J Natl Cancer Inst 96(4):248-249.

*Dragnev KH, Feng Q, Ma Y, Shah SJ, Black C, Memoli V, Nugent W, Rigas JR, Kitareewan S, Freemantle S, Dmitrovsky E (2007). Uncovering novel targets for cancer chemoprevention. Recent Results Cancer Res 174:235-243.

*Dragnev KH, Petty WJ, Dmitrovsky E (2003). Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2(4 Suppl 1):S150-S156.

*Dragnev KH, Petty WJ, Ma Y, Rigas JR, Dmitrovsky E (2005). Nonclassical retinoids and lung carcinogenesis. Clin Lung Cancer 6(4):237-244.

*Dragnev KH, Petty WJ, Shah S, Biddle A, Desai NB, Memoli V, Rigas JR, Dmitrovsky E (2005). Bexarotene and erlotinib for aerodigestive tract cancer. J Clin Oncol 23(34):8757-8764.

*Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, Nugent WC, Hermann T, Negro-Vilar A, Rigas JR, Dmitrovsky E (2007). A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clin Cancer Res 13(6):1794-1800.

*Dragnev KH, Pitha-Rowe I, Ma Y, Petty WJ, Sekula D, Murphy B, Rendi M, Suh N, Desai NB, Sporn MB, Freemantle SJ, Dmitrovsky E (2004). Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: Implications for combination therapy. Clin Cancer Res 10(7):2570-2577.

*Dragnev KH, Stover D, Dmitrovsky E (2003). Lung cancer prevention: The guidelines. Chest 123(1 Suppl):60S-71S.

Drinane M, Walsh J, Mollmark J, Simons M, Mulligan-Kehoe MJ (2006). The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions. J Biol Chem 281(44):33336-33344.

*Fadul CE, Kominsky AL, Meyer LP, Kingman LS, Kinlaw WB, Rhodes CH, Eskey CJ, Simmons NE (2006). Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 105(4):621-626.

*Fortuny J, Kogevinas M, Zens MS, Schned A, Andrew AS, Heaney J, Kelsey KT, Karagas MR (2007). Analgesic and anti-inflammatory drug use and risk of bladder cancer: A population based case control study. BMC Urol 7:13.

*Freemantle SJ, Dragnev KH, Dmitrovsky E (2006). The retinoic acid paradox in cancer chemoprevention. J Natl Cancer Inst 98(7):426-427.

*Freemantle SJ, Spinella MJ, Dmitrovsky E (2003). Retinoids in cancer therapy and chemoprevention: Promise meets resistance. Oncogene 22(47):7305-7315.

*Freemantle SJ, Vaseva AV, Ewings KE, Bee T, Krizan KA, Kelley MR, Hattab EM, Memoli VA, Black CC, Spinella MJ, Dmitrovsky E (2007). Repression of cyclin D1 as a target for germ cell tumors. Int J Oncol 30(2):333-340.

Ganem NJ, Compton DA (2004). The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK. J Cell Biol 166(4):473-478.

*Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67(6):2456-2468.

*Giuliano CJ, Kerley-Hamilton JS, Bee T, Freemantle SJ, Manickaratnam R, Dmitrovsky E, Spinella MJ (2005). Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta 1731(1):48-56.

Gladfelter AS, Hungerbuehler AK, Philippsen P (2006). Asynchronous nuclear division cycles in multinucleated cells. J Cell Biol 172(3):347-362.

*Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT (2005). Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer 104(9):1918-1923.

*Honda T, Janosik T, Honda Y, Han J, Liby KT, Williams CR, Couch RD, Anderson AC, Sporn MB, Gribble GW (2004). Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets. J Med Chem 47(20):4923-4932.

*Hsu M, Mabaera R, Lowrey CH, Martin DI, Fiering S (2007). CpG hypomethylation in a large domain encompassing the embryonic {beta}-like globin genes in primitive erythrocytes. Mol Cell Biol 27(13):5047-5054.

Hu X, Eszterhas S, Pallazzi N, Bouhassira EE, Fields J, Tanabe O, Gerber SA, Bulger M, Engel JD, Groudine M, Fiering S (2007). Transcriptional interference among the murine beta-like globin genes. Blood 109(5):2210-2216.

Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, Slingluff CL, Jr., Brinckerhoff CE (2004). Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: Role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem 279(32):33168-33176.

Jagasia R, Grote P, Westermann B, Conradt B (2005). DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature 433(7027):754-760.

Jager S, Schwartz HT, Horvitz HR, Conradt B (2004). The Caenorhabditis elegans F-box protein SEL-10 promotes female development and may target FEM-1 and FEM-3 for degradation by the proteasome. Proc Natl Acad Sci U S A 101(34):12549-12554.

Jones SB, DePrimo SE, Whitfield ML, Brooks JD (2005). Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 14(3):596-604.

Jude CD, Climer L, Xu D, Artinger E, Fisher JK, Ernst P (2007). Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell 1:324-337.

*Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M (2006). Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98(6):389-395.

*Karagas MR, Park S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT (2005). Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: A population-based case-control study. Int J Hyg Environ Health 208(5):321-327.

*Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005). Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: A population-based study. Cancer Lett 219(1):63-69.

*Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M (2007). Measures of cumulative exposure from a standardized sun exposure history questionnaire: A comparison with histologic assessment of solar skin damage. Am J Epidemiol 165:719-726.

*Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Andrew A, Nelson HH, Colt J, Baris D, Morris JS, Schned A, Karagas M (2005). TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int J Cancer 117(3):370-375.

*Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR (2004). A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer 90(8):1572-1576.

*Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ (2005). A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma. Oncogene 24(40):6090-6100.

*Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW (2005). Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Clin Endocrinol (Oxf) 63(6):676-682.

*Kitareewan S, Roebuck BD, Demidenko E, Sloboda RD, Dmitrovsky E (2007). Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J Natl Cancer Inst 99(1):41-52.

Kundu M, Compton S, Garrett-Beal L, Stacy T, Starost MF, Eckhaus M, Speck NA, Liu PP (2005). Runx1 deficiency predisposes mice to T-cell lymphoblastic lymphoma. Blood 106:3621-3624.

*Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J (2007). Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 67(2):501-510.

Li N, Li H, Cherukuri P, Farzan S, Harmes DC, DiRenzo J (2006). TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Oncogene 25(16):2349-2359.

Li Z, Chen MC, Stacy T, Speck NA (2006). Runx1 function in hematopoiesis is required in cells that express Tek. Blood:106-110.

Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102(16):5814-5819.

*Liby K, Royce DB, Williams CR, Risingsong R, Yore MM, Honda T, Gribble GW, Dmitrovsky E, Sporn TA, Sporn MB (2007). The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res 67(6):2414-2419.

Liu Y, Cheney MD, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH (2006). The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9(4):249-260.

Longnecker DS, Adsay NV, Fernandez-del Castillo C, Hruban RH, Kasugai T, Klimstra DS, Kloppel G, Luttges J, Memoli VA, Tosteson TD, Yanagisawa A, Wilentz R, Zamboni G (2005). Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: Interobserver agreement. Pancreas 31(4):344-349.

Loring GL, Christensen KC, Gerber SA, Brenner C (2008, In press). Yeast CHfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent. Cell Cycle.

*Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E, Freemantle SJ, Dmitrovsky E (2007). Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A 104(10):4089-4094.

*Ma Y, Koza-Taylor PH, DiMattia DA, Hames L, Fu H, Dragnev K, Turi T, Beebe JS, Freemantle SJ, Dmitrovsky E (2003). Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene 22:4924-4932.

*Mabaera RH, Richardson CA, Johnson KJ, Hsu M, Fiering SH, Lowrey CH (2007). Developmental and differentiation-specific patterns of human {gamma} and {beta}-globin promoter DNA methylation. Blood 110(4):1343-1352.

Manning AL, Ganem NJ, Bakhoum SF, Wagenbach M, Wordeman L, Compton DA (2007). The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 18(8):2970-2979.

Manuylov NL, Smagulova FO, Tevosian SG (2007). Fog2 excision in mice leads to premature mammary gland involution and reduced Esr1 gene expression. Oncogene 26(36):5204-5213.

*Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT (2005). Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 65(16):7081-7085.

*Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT (2006). Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27(1):112-116.

Matheny CJ, Speck ME, Cushing PR, Zhou Y, Corpora T, Regan M, Newman M, Roudaia L, Speck CL, Gu TL, Griffey SM, Bushweller JH, Speck NA (2007). Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles. Embo J 26(4):1163-1175.

*McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, Flashman LA, Rhodes CH (2004). Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments. Curr Psychiatry Rep 6(5):364-371.

McAllister TW, Rhodes CH, Flashman LA, McDonald BC, Belloni D, Saykin AJ (2005). Effect of the dopamine d2 receptor T allele on response latency after mild traumatic brain injury. Am J Psychiatry 162(9):1749-1751.

*Mix KS, Coon CI, Rosen ED, Suh N, Sporn MB, Brinckerhoff CE (2004). Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: A role for Smad signaling. Mol Pharmacol 65(2):309-318.

*Mulligan-Kehoe MJ, Schwartz GN, Zacharski LR (2006). The functions of plasminogen activator inhibitor-1: Do we have all the pieces of PAI? Thromb Res 117(5):483-486.

*North WG, Memoli VA, Keegan BP (2005). Immunohistochemical detection of NRSA on small cell lung cancer with a monoclonal antibody (MAG-1) that recognizes the carboxyl terminus of provasopressin. Appl Immunohistochem Mol Morphol 13(4):363-366.

*North WG, Wells W, Fay MJ, Mathew RS, Donnelly EM, Memoli VA (2003). Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS). Endocr Pathol 14(3):257-262.

*Perez RP, Lewis LD, Beelen AP, Olszanski AJ, Johnston N, Rhodes CH, Beaulieu B, Ernstoff MS, Eastman A (2006). Modulation of cell cycle progression in human tumors: A pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 Inhibitor UCN-01 (NSC 638850). Clin Cancer Res 12(23):7079-7085.

Petrella BL, Brinckerhoff CE (2006). Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase. Mol Cancer 5:66.

Petty WJ, Dragnev KH, Dmitrovsky E (2003). Cyclin D1 as a target for chemoprevention. Lung Cancer Suppl 1:S155-S161.

*Petty WJ, Dragnev KH, Memoli VA, Ma Y, Desai NB, Biddle A, Davis TH, Nugent WC, Memoli N, Hamilton M, Iwata KK, Rigas JR, Dmitrovsky E (2004). Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Clin Cancer Res 10(22):7547-7554.

*Petty WJ, Li N, Biddle A, Bounds R, Nitkin C, Ma Y, Dragnev KH, Freemantle SJ, Dmitrovsky E (2005). A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 97(22):1645-1651.

*Pipas JM, Meyer LP, Rhodes CH, Cromwell LD, McDonnell CE, Kingman LS, Rigas JR, Fadul CE (2005). A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. J Neurooncol 71(3):301-305.

*Pitha-Rowe I, Petty WJ, Feng Q, Koza-Taylor PH, Dimattia DA, Pinder L, Dragnev KH, Memoli N, Memoli V, Turi T, Beebe J, Kitareewan S, Dmitrovsky E (2004). Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention. Cancer Res 64(21):8109-8115.

*Reif DM, Israel MA, Moore JH (2007, In press). Exploratory visual analysis of statistical results from microarray experiments comparing high and low grade glioma. Cancer Informatics.

Saito RM, Perreault A, Peach B, Satterlee JS, van den Heuvel S (2004). The CDC-14 phosphatase controls developmental cell-cycle arrest in C. elegans. Nat Cell Biol 6(8):777-783.

Schertel C, Conradt B (2007). C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions. Development 134(20):3691-3701.

*Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR (2007). Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO Classification Systems. J Urol 178(4):1196-1200.

Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5(3):R13.

*Tada T, Nguyen JB, Hitoshi Y, Watson NP, Dunn JF, Ohara S, Nagano S, Kosai K, Israel MA (2005). Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirus. Neurol Res 27(4):378-386.

Tempel W, Rabeh WM, Bogan KL, Belenky M, Wojcik M, Seidle HF, Nedyalkova L, Yang T, Sauve AA, Park HW, Brenner C (2007). Nicotinamide riboside kinase structures reveal new pathways to NAD+. PLoS Biology 5:e263.

Trapasso F, Krakowiak A, Cesari R, Arkles J, Yendamuri S, Ishii H, Vecchione A, Kuroki T, Bieganowski P, Huebner K, Croce CM, Brenner C (2003). Designed FHIT  alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate-binding. Proc Natl Acad Sci U S A 100:1592-1597.

*Vincenti MP, Brinckerhoff CE (2007). Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: Can MMPs be good for you? J Cell Physiol 213(2):355-364.

Whitfield ML, George LK, Grant GD, Perou CM (2006). Common markers of proliferation. Nat Rev Cancer 6(2):99-106.

*Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH (2006). Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 67(7):1221-1224.

*Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW (2006). Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry 163(9):1603-1610.

*Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ (2007). Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene 26(7):1046-1055.

*Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH (2007). Atypical teratoid/rhabdoid tumor of the spine in an adult: Case report and review of the literature. J Neurooncol 84(1):49-55.

Zhuang ZW, Gao L, Murakami M, Pearlman JD, Sackett TJ, Simons M, de Muinck ED (2006). Arteriogenesis: Noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents. Radiology 240(3):698-707.